Unknown

Dataset Information

0

Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci.


ABSTRACT: Factor V Leiden (F5L ) is a common genetic risk factor for venous thromboembolism in humans. We conducted a sensitized N-ethyl-N-nitrosourea (ENU) mutagenesis screen for dominant thrombosuppressor genes based on perinatal lethal thrombosis in mice homozygous for F5L (F5L/L ) and haploinsufficient for tissue factor pathway inhibitor (Tfpi+/- ). F8 deficiency enhanced the survival of F5L/LTfpi+/- mice, demonstrating that F5L/LTfpi+/- lethality is genetically suppressible. ENU-mutagenized F5L/L males and F5L/+Tfpi+/- females were crossed to generate 6,729 progeny, with 98 F5L/LTfpi+/- offspring surviving until weaning. Sixteen lines, referred to as "modifier of Factor 5 Leiden (MF5L1-16)," exhibited transmission of a putative thrombosuppressor to subsequent generations. Linkage analysis in MF5L6 identified a chromosome 3 locus containing the tissue factor gene (F3). Although no ENU-induced F3 mutation was identified, haploinsufficiency for F3 (F3+/- ) suppressed F5L/LTfpi+/- lethality. Whole-exome sequencing in MF5L12 identified an Actr2 gene point mutation (p.R258G) as the sole candidate. Inheritance of this variant is associated with suppression of F5L/LTfpi+/- lethality (P = 1.7 × 10-6), suggesting that Actr2p.R258G is thrombosuppressive. CRISPR/Cas9 experiments to generate an independent Actr2 knockin/knockout demonstrated that Actr2 haploinsufficiency is lethal, supporting a hypomorphic or gain-of-function mechanism of action for Actr2p.R258G Our findings identify F8 and the Tfpi/F3 axis as key regulators in determining thrombosis balance in the setting of F5L and also suggest a role for Actr2 in this process.

SUBMITTER: Westrick RJ 

PROVIDER: S-EPMC5594664 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


Factor V Leiden (<i>F5</i><sup><i>L</i></sup> ) is a common genetic risk factor for venous thromboembolism in humans. We conducted a sensitized <i>N</i>-ethyl-<i>N</i>-nitrosourea (ENU) mutagenesis screen for dominant thrombosuppressor genes based on perinatal lethal thrombosis in mice homozygous for <i>F5</i><sup><i>L</i></sup> (<i>F5</i><sup><i>L/L</i></sup> ) and haploinsufficient for tissue factor pathway inhibitor (<i>Tfpi</i><sup><i>+/-</i></sup> ). <i>F8</i> deficiency enhanced the surviv  ...[more]

Similar Datasets

| S-EPMC2902284 | biostudies-literature
| S-EPMC4543426 | biostudies-literature
| S-EPMC5409503 | biostudies-literature
| S-EPMC6193042 | biostudies-literature
| S-EPMC10468300 | biostudies-literature
| S-EPMC10028809 | biostudies-literature
| S-EPMC7093148 | biostudies-literature
| S-EPMC2681771 | biostudies-literature
| S-EPMC3959233 | biostudies-literature
| S-EPMC2771327 | biostudies-literature